Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Not yet recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
/vufind/Search/Results?lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
Search /vufind/Search2/Results?lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
PubPharm (320.034)
1
An MR-scan study of Liraglutide on cardiac function and cardiac blood flow in patients with type 2 diabetes and impaired filling of the heart. : Influence of liraglutide on diastolic cardiac function and myocardial perfusion as determined by magnetic resonance imaging in patients with type 2 diabetes: a double-blind randomized parallel-group trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A clinical trial for advanced prostatic cancer patients . The study medication will be Leuprolide Mesylate, which will be administered as an injection twice. Both the study doctors and clinical trial participants know which treatment is being administered, there will be only one treatment group.The safety and efficacy of the medicinal product will be tested during the study. : An Open-Label, Single-Arm Study of the Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate for Injectable Suspension (LMIS 50 mg) in Subjects with Advanced Prostate Carcinoma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to investigate the safety and immunogenicity of different formulations of GSK Biologicals’ Meningococcal ACWY conjugate vaccine (GSK3536820A and Menveo) administered to healthy adults 18 to 40 years of age : A phase 2b, randomized, controlled, observer-blind, multi-center, non-inferiority immunogenicity and safety study of two formulations of GSK Biologicals’ Meningococcal ACWY conjugate vaccine (GSK3536820A and Menveo) administered to healthy adults 18 to 40 years of age. - MENACWY CONJ-032_V59_71
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC) : An Exploratory Study of the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Phase 2 Global Study conducted to see the benefit and safety of CC-486 alone and in combination with Durvalumab (MEDI4736) in patients with Myelodysplastic Syndromes who Did Not Respond to Treatment With Azacitidine for injection or Decitabine. : A Phase 2, International, Multicenter, Randomized, Open-label, Parallel Group Study to Evaluate the Efficacy and Safety of CC-486 (oral azacitidine) Alone and in Combination with Durvalumab (MEDI4736) in Subjects With Myelodysplastic Syndromes Who Fail to Achieve an Objective Response to Treatment With Azacitidine for Injection or Decitabine
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Repeat dose study of GSK3772847 in participants with moderate to severe asthma with allergic fungal airway disease (AFAD) : A double blind (sponsor open) placebo-controlled, stratified, parallel group study to evaluate the efficacy and safety of repeat doses of GSK3772847 in participants with moderate to severe asthma with allergic fungal airway disease (AFAD). - PH2a,12-week, 3 RD of 10 mg/kg IV every 4 weeks, efficacy and safety study in asthma pts with AFAD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
New therapy for patients suffering Acute Respiratory Distress Syndrome : Therapeutic Iloprost for the treatment of Acute Respiratory Distress Syndrome (ARDS) (the ThIlo-Trial): a prospective, randomized, multicenter phase II study - Thllo
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Evaluating the efficacy and safety of pertuzumab in combination with trastuzumab and chemotherapy in patients with HER2-positive metastatic gastro-esophageal junction and gastric cancer : A double-blind, placebo-controlled, randomized, multicenter phase III study evaluating the efficacy and safety of pertuzumab in combination with trastuzumab and chemotherapy in patients with HER2-positive metastatic gastro-esophageal junction and gastric cancer - JACOB
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A clinical study to compare brincidofovir with current care for adenovirus infection in children after a bone marrow transplant : An Open-label, Randomized, Multi-center, Parallel Group, Two-arm Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir versus Standard of Care for Treatment of Adenovirus Infections in High-risk Pediatric Allogeneic Hematopoietic Cell Transplant Recipients - AdAPT: Adenovirus after Allogeneic Pediatric Transplantation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32004]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Medienart
320.034
Aufsätze
320.034
E-Artikel
320.034
E-Ressourcen
Zeitschriftentitel
320.034
WHO International Clinical Trials Registry Plat...
Thema
320.034
610
Recruitment Status: Not yet recruiting
271.124
Study Type: Interventional
51.790
Phase: Phase 3
38.240
Study Type: Observational
37.542
Phase: Phase 2
14.680
Phase: Phase 4
8.476
Phase: Phase 1
4.394
Phase: Other
4.252
Phase: Phase 2/Phase 3
4.066
Phase: New Treatment Measure Clinical Study
3.158
Medical Condition: Health Condition 1: O- Medic...
2.926
Study Type: Diagnostic test
2.886
Phase: Retrospective study
2.238
Phase: Phase 1/Phase 2
1.904
Study Type: Observational non invasive
1.304
Study Type: Basic Science
1.240
Phase: Phase 3/Phase 4
1.172
Study Type: Relative factors research
1.164
Phase: Post-market
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
187.596
2020-
132.438
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
312.358
Englisch
3.352
Unbestimmt
2.288
Spanisch
546
Niederländisch
396
Deutsch
394
Französisch
194
Dänisch
134
Finnisch
94
Italienisch
40
Sanskrit
34
Schwedisch
26
Portugiesisch
20
Galizisch
18
Tschechisch
16
Norwegisch
14
Ungarisch
12
Slowakisch
10
Irisch
10
Latein
8
Isländisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...